Millavelez, Cris .

HRN: 28-85-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2026
CEFUROXIME 750MG (VIAL)
04/13/2026
04/19/2026
IV
750mg
Q12
UTI
Remove - Pending Acceptance
04/17/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/17/2026
04/24/2026
PO
4ml
BID
UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: